Novo's Wegovy beats Lilly’s Zepbound in real-world study for heart diseases
Seeking Alpha   2 days ago
ads
Read Full Story
Novo's Wegovy beats Lilly’s Zepbound in real-world study for heart diseases  Seeking AlphaWeight loss drugs can halve heart patients’ risk of early death, study finds  The GuardianNovo Nordisk's Wegovy® cuts risk of heart attack, stroke or death by...